Expert Directory

Katherine Foss, Ph.D.

Professor, Journalism and Strategic Media, College of Media and Entertainment

Middle Tennessee State University

Journalism and Strategic Media, media studies, Health Communication, Gender Studies

Katherine A. Foss (Ph.D., Mass Communication, University of Minnesota), is professor of Media Studies in the School of Journalism & Strategic Media at Middle Tennessee University and an award-winning scholar. Her research broadly examines facets of health communication, including the history of media and epidemics, breastfeeding discourse, and parasocial interactionism and grief. Previous studies have addressed children’s media literacy, gender and victimization, hearing loss, and other topics related to entertainment media.

She is the author of Constructing the Outbreak: Epidemics in Media and Collective Memory (University of Massachusetts Press, 2020), a book that encompasses more than 200 years of media coverage of epidemics. Past books also include Breastfeeding and Media: Exploring Conflicting Discourses That Threaten Public Health (2017, Palgrave Macmillan), and Television and Health Responsibility in an Age of Individualism (2014, Lexington Books). She has also produced more than two dozen publications that include op-eds, essays, reviews, book chapters, encyclopedia entries, and peer-reviewed articles in Journalism & Mass Communication Quarterly, Health Communication, Critical Studies in Media Communication, and other journals. Foss also served as the editor for The Graduate Student Guidebook: From Orientation to Tenure Track (forthcoming, Rowman & Littlefield), Beyond Princess Culture: Gender and Children’s Marketing (2019, Peter Lang Publishing) and Demystifying the Big House: Exploring Prison Experience and Media Representations (2018, Southern Illinois Press University). 

She serves as the on the Board of Directors for the Association of Education in Journalism & Mass Communication and on the editorial boards of Health Communication and the Image of the Journalist in Popular Culture. She was an invited speaker at the 2012 Great Nurse-In, a breastfeeding advocacy event held on the West Lawn of Capitol Hill in Washington, D.C. She also won the 2013 Covert Award and the 2012 James W. Carey Media Research Award and the for her co-authored article (with Dr. Kathy Forde) published in Book History.

Ian Foster, Ph.D.

Senior Scientist and Distinguished Fellow - Director of the Data Science and Learning Division, at Argonne National Laboratory - Arthur Holly Compton Distinguished Service Professor of Computer Science at the University of Chicago

Globus

Computer Science, data science, data-intensive computing technologies

Dr. Foster is Senior Scientist and Distinguished Fellow, and also director of the Data Science and Learning Division, at Argonne National Laboratory, and the Arthur Holly Compton Distinguished Service Professor of Computer Science at the University of Chicago. His research deals with distributed, parallel, and data-intensive computing technologies, and innovative applications of those technologies to scientific problems in such domains as materials science, climate change, and biomedicine. He is a fellow of the AAAS, ACM, BCS, and IEEE, and an Office of Science Distinguished Scientists Fellow. His awards include the BCS Lovelace Medal and IEEE Babbage and Kanai awards.

workplace power dynamics, Social Perception, interpersonal influence behaviors, Workplace Incivility, Organizational Behavior, Leadership

Dr. Trevor Foulk is an Assistant Professor of Management & Organization at the Robert H. Smith School of Business at the University of Maryland.  He received his Ph.D. in Organizational Behavior from the Warrington College of Business at the University of Florida, and his Bachelors of Business Administration from the University of Massachusetts.

Dr. Foulk’s research interests include deviant workplace behaviors, workplace power dynamics, social perception, and interpersonal influence behaviors.  His research has been published in the Academy of Management Journal, the Journal of Applied Psychology, the Journal of Organizational Behavior, Organizational Dynamics, and Pediatrics.  Dr. Foulk has contributed articles to Time Magazine, Harvard Business Review, and the USA Today, and his work has been featured in the Wall Street Journal, People Magazine, Scientific American, Fortune, The Huffington Post, New York Magazine, the Boston Globe, the LA Times, ABC News, and NBC News.

Epidemiology, Statistical Epidemiology, integrative biology

Spencer J. Fox is Associate Director of The University of Texas at Austin COVID-19 Modeling Consortium and a research associate at UT Austin. His expertise is in statistical modeling of infectious diseases and machine learning, and his research focuses on understanding emerging infectious diseases and pandemics, as well as developing response tools for public health officials. He earned his undergraduate degree in Biology at Rose-Hulman Institute of Technology and received a doctoral degree in Integrative Biology from the University of Texas at Austin in 2018, working with Professor Lauren Ancel Meyers. 

 

Fellowships & Awards

National Geographic Young Explorer (2017)

UT Austin recruitment fellowship (2013)

Ehlers-Danlos Syndrome, EDS, Skeletal Dysplasia, Hypermobility Spectrum Disorders

Dr. Clair Francomano has been involved in the care of individuals with the Ehlers-Danlos Syndromes throughout her career. During her years at the National Institutes of Health, she spear-headed a longitudinal study on the natural history of EDS that ran for over 20 years. She has served on the Steering Committee for the International Consortium on the Ehlers-Danlos Syndromes and Related Conditions and as chair of the Committee on Classical Ehlers-Danlos Syndrome for the Consortium since 2016.

Dr. Francomano joined Indiana University in August 2019 as professor of medical and molecular genetics at the IU School of Medicine and director of the Residency Training Program in Genetics at IU. Prior to joining IU, she was the director of the Ehlers-Danlos National Foundation Center for Clinical Care and Research at the Harvey Institute of Human Genetics, Greater Baltimore Medical Center, which she joined in 2005 as director of adult genetics

Dr. Francomano's research interests over the years have centered on hereditary disorders of connective tissue and skeletal dysplasias. In 1994, she became Chief of the Medical Genetics Branch at the National Human Genome Research Institute, National Institutes of Health, where she served as Clinical Director from 1996-2001. From 2001-2005 she was Chief of the Human Genetics and Integrative Medicine Section in the Laboratory of Genetics, National Institute on Aging. She has published over 130 peer-reviewed articles and lectures widely around the world about the Ehlers-Danlos Syndromes and related disorders. She has a keen interest in the management of the multiple co-morbidities seen in this condition.  

Dr. Francomano attended Yale College as an undergraduate and received her M.D. from Johns Hopkins University School of Medicine, where she trained in internal medicine and medical genetics. She joined the full-time Hopkins faculty in 1984.  

James L. Frazier III, M.D.

Chief, Neurosurgery, Northwest Hospital

LifeBridge Health

Neck Pain, arm pain, Low Back Pain, Leg Pain, Lumbar Stenosis, non-surgical spine care, Spinal Cord Stimulation, spinal tumor ablation, Spine Tumors, Spine trauma, cervical conditions

Dr. Frazier completed a neurosurgical residency at the Johns Hopkins Hospital after earning a medical degree from the Johns Hopkins University School of Medicine and an undergraduate degree magna cum laude from Brown University in Providence, Rhode Island. As a medical student, Dr. Frazier received the Hunterian Medical Student Research Award for his work on interstitial chemotherapy for brain tumors. During his training, Dr. Frazier completed specialized fellowships in neuro-oncology and radiosurgery.

rare disease, Rare Disease Day, congenital disorders of glycosylation, cdg, CDGs

Hudson Freeze helps doctors and families get often long-awaited answers about their child’s rare disease. His lab focuses on developing tests for congenital disorders of glycosylation, or CDGs, an umbrella term for more than 140 mutations that disrupt sugar linking.

First discovered in the 1990s, children with CDG have varying degrees of speech and language difficulty, poor balance, motor control, vision problems, hearing impairments and seizures. 

Remarkably, children with two specific CDG mutations who receive simple nutritional supplements can have dramatic symptom improvements—sometimes even living relatively normal lives. However, for the remaining 140 mutations, no treatments exist.

Emily Frye, Doctor of Jurisprudence

Director, Cyber Integration

MITRE

Homeland Security, National Security, Critical Infrastructure, Cybersecurity

Emily Frye is Director for Cyber Integration at the Homeland Security Center at The MITRE Corporation. She is an expert on homeland security, critical infrastructure and cybersecurity.
Frye’s work has helped define and explore options for the future of comprehensive, nationwide cybersecurity approaches across both public and private sectors, bridge the divide between federal and state government on cybersecurity initiatives, and strengthen public-private partnerships in support of critical infrastructure security and resilience. 
Frye has served on both the Long-Range Planning Committee for the Section of Science & Technology of the American Bar Association, and as advisor to the Diversity Committee of the American Bar Association. She is an accomplished speaker and moderator, and has written about issues relating to critical infrastructure, national resilience, digital technology, national security, privacy, economic impacts of cybersecurity, and the role of insurance in Critical Infrastructure Protection. She received her Doctor of Jurisprudence degree from George Mason University and her undergraduate degree from William & Mary.  
Her speaking appearances include a cybersecurity conference hosted by the Atlantic Council in Poland and Xconomy’s Cyber Madness. She has also written in The Hill on the need for an international cyber court, and been quoted by Slate and CybersecurityTV.

Charles Fuchs, MD, MPH

Professor; Director; Physician-in-Chief

Yale Cancer Center

Colorectal Cancer, Gastrointestinal Cancer, Yale Cancer Center, Cancer epidemiology, Cancer Prevention and Control

Charles S. Fuchs, MD, MPH, became Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital on January 1, 2017. An internationally recognized expert in gastrointestinal cancers and cancer epidemiology, Dr. Fuchs was previously profess

Machine Learning, Optimization, Simulation, Decision Sceince, R Coding, Python, Statistics, Sustainability, Modeling, Health Administration

Larry Fulton is an Associate Professor of Health Administration at Texas State University, San Marcos. He earned his Doctorate of Philosophy / Masters of Science in Statistics from the University of Texas at Austin, his Master of Health Administration from Baylor, and three other graduate degrees. Dr. Fulton is a Fellow of the American College of Healthcare Executives (FACHE) and maintains the credentials of Chartered Scientist and Chartered Statistician (CStat CSci) as a Fellow in the Royal Statistical Society. He is a Certified Analytics Professional (CAP) of the Institute for Operations Research & Management Science, a Certified Quality Engineer and Certified Six Sigma Black Belt (CQE CSSBB) of the American Society for Quality and a Professional Statistician (PStat) of the American Statistical Association.

Ophthalmology, ocular oncology, Vitreoretinal Surgery, Retinal and vitreous diseases

Timothy G. Murray, MD, MBA, is the Immediate Past President of the American Society of Retina Specialists (ASRS) and the Founding Director/CEO of Ocular Oncology and Retina of Miami Florida (MOOR). After 21 years at the Bascom Palmer Eye Institute, Dr. Murray is Professor Emeritus of Ophthalmology and Radiation Oncology, Sylvester Comprehensive Cancer Center of the University of Miami Miller School of Medicine. 

Dr. Murray’s primary focus is in ocular oncology and retinal disease. He has been involved in the evaluation of novel treatment approaches for ocular melanoma, retinoblastoma, vascular tumors and has utilized basic and translational laboratory studies to enhance understanding of the molecular and pathogenetic mechanisms for tumor development. Dr. Murray’s interest in new evaluation and treatment technologies has been pivotal in the marked advancements in melanoma and retinoblastoma management in the United States and internationally.

A graduate of the Johns Hopkins School of Medicine in the combined BA/MD program, Dr. Murray completed his residency and chief residency at the University of California, San Francisco and fellowship in vitreoretinal surgery at the Eye Institute, Medical College of Wisconsin. He graduated with a Masters in Business Administration with Health Care focus in 2005.

Dr. Murray has published over 300 peer reviewed articles and chapters in the field of vitreoretinal surgery and ocular oncology. He has been recognized with Honor and Senior Honor awards by the American Academy of Ophthalmology (AAO), the Association for Research in Vision and Ophthalmology (ARVO), the Retina Society, the American Society of Retina Specialists (ASRS), and the International Society of Ocular Oncologists (ISOO).

He is active on multiple editorial boards and as an active editor and peer reviewer for Lasers in Medicine, Retina, Ophthalmology, Archives of Ophthalmology, Investigative Ophthalmology and Visual Science, Retinal Physician and Retina Today.

Dr. Murray is recognized in Top Doctors in America, Top Doctors in Florida, and Top Cancer Doctors in America.

He is an Associate Examiner for the American Board of Ophthalmology, Executive Committee member of the Retina Society, and a member of the Macula Society, Club Jules Gonin and a Fellow of ARVO and ABO.

Lgbt, transgender children, Adolescent Medicine, Sexuality, HIV

Robert Garofalo, MD, MPH, is the Division Head of Adolescent Medicine at Ann & Robert H. Lurie Children’s Hospital of Chicago and a Professor of Pediatrics at Northwestern University Feinberg School of Medicine. He is a Co-Director of Lurie Children’s Gender and Sex Development Program, the first comprehensive program for gender nonconforming children and adolescents in the Midwest. Dr. Garofalo also directs Lurie Children’s Adolescent/Young Adult HIV Program and the Center for Gender, Sexuality and HIV Prevention, which conducts research on topics in adolescent sexual health, gender, sexuality, HIV prevention and health disparities affecting adolescent and young adult populations at risk of acquiring HIV. He is a national expert on lesbian, gay, bisexual and transgender (LGBT) health issues in youth, as well as adolescent sexuality and HIV clinical care and prevention. Dr. Garofalo is the former President of the Gay and Lesbian Medical Association. In 2010, he served as a committee member for the National Academy of Sciences/Institute of Medicine Committee on Lesbian, Gay, Bisexual and Transgender Health Issues and Research Gaps and Opportunities.  

Disease, Neurodegenerative Disorder, Amyothrophic Lateral Sclerosis, Parkinson's Disease, Alzheimer's Disease, Food Chain, Obesity, Malaria

Garruto’s research interests include natural experimental models of disease, using both field and laboratory approaches. His cross-disciplinary research and interests include studies of neurodegenerative disorders including amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease, food chain disorders, health transition studies, obesity and bionutrition, malaria, Lyme and other tick-borne diseases, and prion diseases, especially chronic wasting disease. 

Marie-Claire Gauduin, Ph.D.

Assoc. Scientist, Virology & Immunology

Texas Biomedical Research Institute

HIV, AIDS

Dr. Gauduin has more than 25 years of experience in HIV/AIDS research and medical microbiology. She has been working extensively on HIV and the development of novel vaccine strategies using the non-human primate model for AIDS. In her work, she uses epithelial stem cells and weakened recombinant papillomavirus as vaccine- vectors to protect against multiple low-dose mucosal challenges. Dr. Gauduin is also developing a neonatal model for tuberculosis to study HIV/TB co-infection in pediatric AIDS.

Her specific research interests are:

Early events of simian immunodeficiency virus (SIV) transmission in a macaque model
Host immune responses to infectious diseases
Early virus-specific T cell responses in neonates
Tuberculosis/SIV coinfection in pediatric AIDS

Energy, Energy Economics, U.S. Energy Policy, Electric Power Industry, Wind Power, business economics

Michael Giberson is an associate professor of practice in the Jerry S. Rawls College of Business at Texas Tech University. He is an expert in the areas of energy economics, U.S. energy policy and the electric power industry. Giberson's research and writing focuses on U.S. energy policy and electric power markets, and on the law and economics of price gouging. He is a faculty affiliate at the Free Market Institute at Texas Tech University. Prior to joining Texas Tech in 2008 he worked with Potomac Economics, Ltd., an economic consulting firm specializing in the electric power industry. Michael Giberson has been published in Nature Energy, the Electricity Journal, the Journal of Regulatory Economics, the Pacific and Asian Journal of Energy, and Regulation magazine, and has written on U.S. energy policies and federal electric power issues for trade publications. He is co-author with Lynne Kiesling of the Knowledge Problem blog discussing economics, energy policy, technology and many other topics. Energy posts at Knowledge Problem are included at Social Media Today's The Energy Collective online community. In addition, his commentary and analysis has appeared at Alternative Energy Stocks and MasterResource. Giberson earned his bachelor's degree in economics from Texas Tech and his master's and doctorate degrees in economics from George Mason University.

Harvinder Gill

Associate Professor, Whitacre Endowed Chair

Texas Tech University

vaccine delivery, Microsystems, Nanosystems, Bio-Nanomaterials, Mucosal Vaccination, Immunomodulation, Flu Vaccination, Peanut Allergy Vaccine

Harvinder Gill is a graduate advisor, associate professor and Whitacre Endowed Chair of Science and Engineering in the Department of Chemical Engineering within the Texas Tech University Edward E. Whitacre Jr. College of Engineering. He directs the Gil Lab where he and his colleagues perform fundamental and translational research in the fields of drug delivery, vaccines, immunotherapy, and nanomedicine to help address some of the pressing biomedical challenges facing human health. His research integrates the knowledge and tools from various disciplines including engineering, chemistry, biology, immunology, recombinant engineering, and micro-nano-technology. Gill currently works to discover innovative drug and vaccine delivery platforms aimed at maximizing stimulation of mucosal immunity in order to address the challenges related to influenza and HIV infectious diseases as well as developing a delivery system for localized delivery of cancer drugs directly into oral tumors. Dr. Gill also is working on developing a delivery method to eliminate peanut allergies through a grant from the NIH, working to transform pollen grain shells into vehicles for delivery of allergy vaccines, and using microneedles to eliminate the need for regular needles to deliver vaccines. Gill earned his bachelor's degree in chemical engineering from Panjab University in 1994 and his doctorate in bioengineering from the Georgia Institute of Technology in 2007.

atmospheric dynamics, Tropical Cyclones, hurricane forecasting, Hurricane modeling, Physical Oceanography, Hurricane Expert, air-sea interactions, numerical environmental modeling, Coastal Flooding, Coastal Hazards

Predicting the severity of a hurricane can mean the difference between life and death. URI Professor of Oceanography Isaac Ginis makes it his business to predict the power of these ferocious storms with a computer model so successful it was adopted by the National Weather Service. As one of the few scientists worldwide to show the role the ocean plays in hurricanes, Ginis essentially proved that ocean temperature is the most important factor in hurricane intensity and power.

Ginis’s research efforts have resulted in pioneering advances in modeling of the tropical cyclone-ocean interactions that have led to significant improvements in hurricane intensity forecast skills.

His research group has contributed to the development of the Hurricane Weather Research Forecast  model used by the U.S. National Hurricane Center and Joint Typhoon Warning Center for operational forecasting of tropical cyclones in all ocean basins. He is currently leading a project funded by the U.S. Department of Homeland Security to develop advanced modeling capabilities for more accurate representation of hurricane hazards and impacts in Southern New England. The project allows DHS and other agencies to better understand the consequences of coastal and inland hazards associated with extreme hurricanes and Nor’easters and to better prepare coastal communities for future risks.

Cancer, Diabetes, Heart Disease, Genetics, biomolecular chemistry, Oncology

In 1993, Antonio Giordano, M.D., Ph.D., founded the Sbarro Institute with a generous donation from Mario Sbarro, the Founder of the Sbarro restaurant chain, following Dr. Giordano’s discovery of the tumor suppressor gene pRb2. Initially named the Sbarro Institute, the research center was located at Thomas Jefferson University, where Dr. Giordano was a professor.

When Dr. Giordano moved to Temple University in 2002, he and twenty fellow scientists forged a new, three-year alliance with Temple University in Philadelphia, Pennsylvania. Under the new arrangement, the original Sbarro Institute was renamed the Sbarro Health Research Organization, Inc. (SHRO), which includes the Sbarro Institute for Cancer Research and Molecular Medicine at Temple and the SHRO-affiliated laboratory at the University of Siena in Siena, Italy.

Under a 2005 agreement, the Sbarro Institute for Cancer Research and Molecular Medicine received continued funding from Temple and expanded its program to include work on the relationship between obesity and cancer and instituted a new program on molecular therapeutics to explore how molecular genetic research can be applied to patient therapies and diagnostics.

SHRO relies on grants and private donations to fund important biomedical research.

Concussion, concussion and football, traumatic brain injuries, Youth, Neuroplasticity, post-traumatic epilepsy, concussion and sports, Sports-Related Head Injury, Brain Development, helmet studies, Neuroimaging, Genetic Markers

Before joining UCLA, Giza worked on the Yosemite Search and Rescue team. In 2011, he traveled to Afghanistan as a civilian advisor to the U.S. Department of Defense. He co-chaired the American Academy of Neurology committee that developed an evidence-based practice guideline for the management of sports concussions from 2009-2013. He currently serves on advisory committees for traumatic brain injuries/concussion with the U.S. Centers for Disease Control, National Collegiate Athletic Association, Major League Soccer and U.S. Soccer Federation. He has been a clinical consultant for the National Football League, National Hockey League and Major League Soccer. 

Tracy R.G. Gladstone, Ph.D.

Senior Research Scientist and Associate Director

Wellesley College, Wellesley Centers for Women

Mental Health, Psychology, Depression

Tracy R. G. Gladstone, Ph.D., is an associate director and senior research scientist at the Wellesley Centers for Women as well as the inaugural director of the Robert S. and Grace W. Stone Primary Prevention Initiatives, which aims to research, develop, and evaluate programs to prevent the onset of depression and other mental health concerns in children and adolescents. She is also an assistant in psychology at Boston Children’s Hospital, an instructor at Harvard Medical School, and a research scientist at Judge Baker Children’s Center.

At the Wellesley Centers for Women, Gladstone is evaluating an internet-based depression prevention intervention for at-risk adolescents in a multi-site, federally funded trial. As a senior member of the Baer Prevention Initiatives Dissemination Program at Boston Children’s Hospital, she is working on developing and disseminating web-based educational resources for clinicians and for parents who are concerned about depression. She has served as a senior member of the Preventive Intervention Project research team at Judge Baker Children’s Center, which compares two family-based prevention programs for early adolescents at risk for depression because they have a parent with a depressive disorder. She also has developed and piloted a cognitive-behavioral group intervention for women who are recovering from fistula repair surgery in Ethiopia.

Gladstone holds a health service provider psychologist license in Massachusetts and has been trained in evidence-based clinical prevention and intervention protocols. She has conducted prevention-oriented work with children and families, and she has served as a clinical supervisor for researchers working with depressed families, as well as for clinical trainees. She has co-authored a number of peer-reviewed manuscripts reporting the results of her research endeavors and has taken an active role in teaching about depression, prevention, and intervention in local, national, and international settings.
close
2.60073